Barth Heidi, Robinet Eric, Liang T Jake, Baumert Thomas F
Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892, USA.
J Hepatol. 2008 Jul;49(1):134-42. doi: 10.1016/j.jhep.2008.03.012. Epub 2008 Apr 14.
Hepatitis C virus (HCV) is a major cause of chronic liver disease including steatosis, cirrhosis and hepatocellular carcinoma. The development of transgenic mice expressing HCV proteins and the successful repopulation of SCID/Alb-uPA mice with human hepatocytes provides an important tool for unraveling virus-host interactions in vivo. Several of these mouse models exhibit aspects of HCV-related liver disease. Thus, these in vivo models play an important role to further understand the pathogenesis of HCV infection and to evaluate the pre-clinical safety and efficacy of new antiviral compounds against HCV. This review summarizes the most important mouse models currently used to study HCV pathogenesis and infection. Finally, the perspective of these models for future HCV research as well as the design of novel small animal models is discussed.
丙型肝炎病毒(HCV)是慢性肝病的主要病因,包括脂肪变性、肝硬化和肝细胞癌。表达HCV蛋白的转基因小鼠的开发以及用人肝细胞成功重建SCID/Alb-uPA小鼠,为在体内揭示病毒与宿主的相互作用提供了重要工具。其中一些小鼠模型展现出HCV相关肝病的特征。因此,这些体内模型在进一步了解HCV感染的发病机制以及评估针对HCV的新型抗病毒化合物的临床前安全性和有效性方面发挥着重要作用。本综述总结了目前用于研究HCV发病机制和感染的最重要的小鼠模型。最后,讨论了这些模型在未来HCV研究中的前景以及新型小动物模型的设计。